{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Tourmaline Bio, Inc. "},"Symbol":{"label":"Symbol","value":"TRML"},"Address":{"label":"Address","value":"570 SOUTH PRESTON STREET, LOUISVILLE, Kentucky, 40202, United States"},"Phone":{"label":"Phone","value":"+1 502 398-9250"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders."},"CompanyUrl":{"label":"Company Url","value":"https://www.tourmalinebio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"John Walsh","title":"Vice President & Head-Medical Affairs"},{"name":"Sandeep C. Kulkarni","title":"Chief Executive Officer & Director"},{"name":"Susan Dana Jones","title":"Chief Technology Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}